Rajesh Malik
CIK 1706853 · Chief Medical Officer · last filed 2024-09-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
47
Lifetime Open-Market Net
-$3.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. (GTHX) Delisted | Chief Medical Officer | 177,212 | $7.15 | $1.27M | -$3.94M | 42 | 2024-09-18 |
| POINT Biopharma Global Inc. (PNT) Delisted | Director | 0 | $12.50 | $0 | $24.6K | 5 | 2023-12-27 |
Recent Filings · Page 2 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +15,532 | -$13.1K | EDGAR |
| 2022-12-16 | G1 Therapeutics, Inc. (GTHX) Delisted | Exer (M) | +14,000 | $4.2K | EDGAR |
| 2022-11-28 | POINT Biopharma Global Inc. (PNT) Delisted | Buy (P) | +3,700 | $24.6K | EDGAR |
| 2022-09-16 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$275.7K | EDGAR |
| 2022-07-06 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −648 | -$3.4K | EDGAR |
| 2022-06-06 | POINT Biopharma Global Inc. (PNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-02 | G1 Therapeutics, Inc. (GTHX) Delisted | Exer (M) | +10,000 | $3.0K | EDGAR |
| 2022-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +10,555 | -$15.3K | EDGAR |
| 2021-07-08 | POINT Biopharma Global Inc. (PNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-11 | G1 Therapeutics, Inc. (GTHX) Delisted | Exer (M) | +10,000 | $3.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.